EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Region‐specific DNA hydroxymethylation along the malignant progression of IDH ‐mutant gliomas

Taijun Hana iD, Akitake Mukasa iD, Masashi Nomura iD, Genta Nagae iD, Shogo Yamamoto iD, Kenji Tatsuno, Hiroki Ueda, Shiro Fukuda iD, Takayoshi Umeda, Shota Tanaka, Takahide Nejo iD, Yosuke Kitagawa iD und 8 weitere

Cancer Science · 2024

DOI: 10.1111/cas.16127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Taijun Hana und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: DNA Methylation, Isocitrate Dehydrogenase, Kruppel-Like Factor 4, Disease Progression. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The majority of low‐grade isocitrate dehydrogenase‐mutant (IDH mt ) gliomas undergo malignant progression (MP), but their underlying mechanism remains unclear. IDH mt gliomas exhibit global DNA methylation, and our previous report suggested that MP could be partly attributed to passive demethylation caused by accelerated cell cycles. However, during MP, there is also active demethylation mediated by ten‐eleven translocation, such as DNA hydroxymethylation. Hydroxymethylation is reported to potentially contribute to gene expression regulation, but its role in MP remains under investigation. Therefore, we conducted a comprehensive analysis of hydroxymethylation during MP of IDH mt astrocytoma. Five primary/malignantly progressed IDH mt astrocytoma pairs were analyzed with oxidative bisulfite and the Infinium EPIC methylation array, detecting 5‐hydroxymethyl cytosine at over 850,000 locations for region‐specific hydroxymethylation assessment. Notably, we observed significant sharing of hydroxymethylated genomic regions during MP across the samples. Hydroxymethylated CpGs were enriched in open sea and intergenic regions ( p < 0.001), and genes undergoing hydroxymethylation were significantly associated with cancer‐related signaling pathways. RNA sequencing data integration identified 91 genes with significant positive/negative hydroxymethylation‐expression correlations. Functional analysis suggested that positively correlated genes are involved in cell‐cycle promotion, while negatively correlated ones are associated with antineoplastic functions. Analyses of The Cancer Genome Atlas clinical data on glioma were in line with these findings. Motif‐enrichment analysis suggested the potential involvement of the transcription factor KLF4 in hydroxymethylation‐based gene regulation. Our findings shed light on the significance of region‐specific DNA hydroxymethylation in glioma MP and suggest its potential role in cancer‐related gene expression and IDH mt glioma malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationIsocitrate DehydrogenaseKruppel-Like Factor 4Disease ProgressionGliomaBrain NeoplasmsMutationGene Expression Regulation, NeoplasticHumansCpG IslandsFemaleMaleAstrocytomaMiddle Aged5-MethylcytosineAdult

Stichwörter der Autor:innen

5‐hydroxymethyl cytosine (5hmC)gliomahydroxymethylationisocitrate dehydrogenase (IDH)malignant progression

Substanzen

Isocitrate DehydrogenaseKruppel-Like Factor 45-Methylcytosine

Autor:innen und Institutionen

  • Department of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Genome Science & Medicine Laboratory, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Department of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Advanced Data Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Department of Neurological Surgery, University of California, San Francisco, California, USA.

ORCID-Profile: Taijun Hana, Akitake Mukasa, Masashi Nomura, Genta Nagae, Shogo Yamamoto, Shiro Fukuda, Takahide Nejo, Yosuke Kitagawa, Hirokazu Takami

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Hana, T., Mukasa, A., Nomura, M., Nagae, G., Yamamoto, S., Tatsuno, K., Ueda, H., Fukuda, S., Umeda, T., Tanaka, S., Nejo, T., Kitagawa, Y., Yamazawa, E., Takahashi, S., Koike, T., Kushihara, Y., Takami, H., Takayanagi, S., Aburatani, H., & Saito, N. (2024). Region‐specific DNA hydroxymethylation along the malignant progression of IDH ‐mutant gliomas. Cancer Science. https://doi.org/10.1111/cas.16127

Vancouver

Hana T, Mukasa A, Nomura M, Nagae G, Yamamoto S, Tatsuno K, et al. Region‐specific DNA hydroxymethylation along the malignant progression of IDH ‐mutant gliomas. Cancer Science. 2024. doi:10.1111/cas.16127

BibTeX
@article{Hana2024,
  author = {Hana, Taijun and Mukasa, Akitake and Nomura, Masashi and Nagae, Genta and Yamamoto, Shogo and Tatsuno, Kenji and Ueda, Hiroki and Fukuda, Shiro and Umeda, Takayoshi and Tanaka, Shota and Nejo, Takahide and Kitagawa, Yosuke and Yamazawa, Erika and Takahashi, Satoshi and Koike, Tsukasa and Kushihara, Yoshihiro and Takami, Hirokazu and Takayanagi, Shunsaku and Aburatani, Hiroyuki and Saito, Nobuhito},
  title = {Region‐specific DNA hydroxymethylation along the malignant progression of IDH ‐mutant gliomas},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16127}
}
Kostenlos starten →